In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
Tags :Dario Glauser
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising €67.5 million ($72 million) from a syndicate of renowned
Over the past years, Capture Media has played a significant role in shaping the landscape of Engagement Advertising in Switzerland, becoming an essential quality factor for many online campaigns. The company has also introduced fusedeck,
Walder Wyss acted as legal counsel to Ionisos SAS on its recent acquisition of an E-beam sterilization and cross-linking facility from Studer Cables. Studer Cables, a prominent technology company specializing in high-performance cables for various
The team included Christian Wyss (Partner, Corporate / M&A - pictured), Luzius Zumstein (Senior Associate, Corporate / M&A) and Dario Glauser (Trainee, Corporate / M&A).
